Related Experiment Video

Updated: Jun 4, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Penicillium marneffei Infection in AIDS

Stephenie Y N Wong1, K F Wong

  • 1Department of Pathology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong.

Pathology Research International
|February 19, 2011
PubMed

Insights

Penicillium marneffei, a fungus endemic to Southeast Asia, causes an AIDS-defining illness. Early diagnosis and treatment, including antifungal and antiretroviral therapies, are vital for managing penicilliosis.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Penicillium marneffei is a dimorphic fungus endemic in Southeast Asia.
  • It is an opportunistic pathogen causing an AIDS-defining illness in endemic regions.
  • Early diagnosis and prompt treatment are critical for managing penicilliosis.

Purpose of the Study:

  • To summarize the diagnostic and management strategies for Penicillium marneffei infections.
  • To highlight the importance of early intervention in patients with penicilliosis, particularly those with Acquired Immunodeficiency Syndrome (AIDS).

Main Methods:

  • Cytological and histological examination of clinical specimens for prompt diagnosis.
  • Microbiological culture as the gold standard for diagnosis.
  • Established standard antifungal treatment protocols for penicilliosis in AIDS patients.

Main Results:

  • Prompt diagnosis is achievable through cytological and histological methods.
  • Microbiological culture confirms the diagnosis.
  • Standard antifungal treatment combined with early highly active antiretroviral therapy (HAART) is effective.
  • Potential drug interactions between antifungal and antiretroviral treatments require careful management.
  • Secondary prophylaxis can be discontinued once immune function improves.

Conclusions:

  • Effective management of penicilliosis involves early diagnosis and combined antifungal and antiretroviral therapy.
  • Monitoring for drug interactions is essential.
  • Discontinuation of secondary prophylaxis is feasible with improved immune status.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...